Search results
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 2 weeks agoNovavax vaccination program on March 21, 2022 in The Hague, Netherlands. Novavax on Friday said it...
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 1 day agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
Free COVID-19 vaccines could be a thing of the past as federal program is set to expire early
Chicago Sun-Times· 16 hours agoWhen COVID-19 vaccines entered the commercial market, the federal government introduced a program to...
If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now | The Motley Fool
The Motley Fool· 1 week agoIf you'd invested $10,000 in Novavax (NVAX 9.26%) a year ago, you would have made a risky bet. Prior...
Novavax stock soars 40% on Sanofi partnership By Investing.com
Investing.com· 2 weeks agoFor the first quarter, Novavax reported a first-quarter loss per share of $1.05, wider than the...
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 1 day agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of...
Novavax Stock Just Tripled. Is It Too Late to Buy?
Motley Fool via Yahoo Finance· 1 week agoAs part of the deal, Sanofi will co-commercialize Novavax's current coronavirus vaccine worldwide and gains a license to combine < ...
COVID’s New ‘FLiRT’ Variants—What To Know As Experts Fear Summer Surge
Forbes· 2 days agoNew coronavirus variants dubbed “FLiRT” are circulating the world and growing dominant in the U.S.,...
The AstraZeneca vaccine – should you be worried?
The Telegraph via Yahoo News· 2 weeks agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
Why Novavax Stock More Than Doubled Today | The Motley Fool
The Motley Fool· 2 weeks agoThe company is partnering with fellow pharmaceutical company Sanofi (SNY 1.21%) to market Novavax's...